| Role |
Name |
Disclosure |
Details |
| Author | Nazer H Qureshi, MD, Staff Physician, Department of Neurosurgery, University of Arkansas for Medical Sciences | Nothing to disclose | Details | | Coauthor | Griffith Harsh IV, MD, Director of Neurosurgical Oncology, Professor, Department of Neurosurgery, Stanford Medical Center, Stanford University School of Medicine | Nothing to disclose | Details | | Medical Editor | Michael G Nosko, MD, PhD, Chief, Division of Neurosurgery, Director of Neurovascular Surgery, Medical Director of Neuroscience Unit, Associate Professor, Department of Surgery, University of Medicine and Dentistry at New Jersey | Nothing to disclose | Details | | Pharmacy Editor | Francisco Talavera, PharmD, PhD, Senior Pharmacy Editor, eMedicine | Nothing to disclose | Details | | Managing Editor | Allen R Wyler, MD, Medical Director, Northstar Neuroscience, Inc | Nothing to disclose | Details | | CME Editor | Herbert H Engelhard III, MD, PhD, Director, UIC Neuro-Oncology Program, Chief, Division of Neuro-Oncology, Associate Professor, Department of Neurosurgery, University of Illinois at Chicago | Nothing to disclose | Details | | Chief Editor | Allen R Wyler, MD, Medical Director, Northstar Neuroscience, Inc | Nothing to disclose | Details |
Contributor Disclosure
Contributor:
|
Contributor Disclosure: |
| Griffith Harsh IV, Coauthor |
The contributor discloses no conflict of interest. |
|